Back |
home / stock / rexn / rexn message board
Subject | By | Source | When |
---|---|---|---|
I rode out the split in May and | HSTN | investorshub | 02/15/2019 7:42:52 PM |
What I was really trying to say is.... | PennyWorld | investorshub | 02/11/2019 8:26:34 PM |
I agree with everything you said. What I | Crozz | investorshub | 02/11/2019 5:00:47 PM |
disagree.. R/S is not factored into the price. | PennyWorld | investorshub | 02/08/2019 10:48:15 PM |
Insiders are executing options, so that they can | Crozz | investorshub | 02/08/2019 5:11:07 PM |
If you own shares, Vote against the R/S | Crozz | investorshub | 02/08/2019 4:49:25 PM |
DELIST PLEASE this is and will always be | kpisme | investorshub | 02/07/2019 10:46:11 PM |
It really doesn't make any difference whether or | Crozz | investorshub | 02/07/2019 8:39:38 PM |
Longs don't seem to ever get rewarded here. | Crozz | investorshub | 02/07/2019 8:35:56 PM |
I wouldn't get too excited, that was a | Crozz | investorshub | 02/07/2019 8:31:19 PM |
WTF...finally some good news! A patent notification...And they | Crozz | investorshub | 02/07/2019 8:28:32 PM |
Hold tight....Insiders didn't just buy for no reason. | 420man | investorshub | 02/04/2019 1:38:25 PM |
News, Short Squeeze, Breakout and More Instantly...
Rexahn Pharmaceuticals Company Name:
REXN Stock Symbol:
NYSE Market:
FARMINGTON HILLS, Mich., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, today announced that will participate in the H.C. Wainwrigh...
Merger completed with Rexahn Pharmace u ticals c reat ing a Nasdaq-listed Biopharmaceutical Company Focused on Advancing Ocuphire’s Late-Stage Clinical Pipeline of Ophthalmic Drug Candidates Trading under "OCUP" on the Nasdaq Capital Market to begin No...
ROCKVILLE, Md., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NASDAQ:REXN) (“Rexahn”) announced today that the merger transaction between Rexahn and Ocuphire Pharma, Inc. is expected to be effective shortly after 4:00 pm (EST) today, Thursday, November 5, 202...